new controversy over treating asthma with long-acting beta-agonists (salmeterol, formoterol)
April 2010
Please see updated information from the FDA (June 2010) concerning the safe use of long-acting beta-agonists You'll hear new controversy over treating asthma with long-acting beta-agonists (salmeterol, formoterol). ...
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote